ColoCare: colorectal cancer survivorship and prognosis

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11210537

This project follows people newly diagnosed with colorectal cancer to find blood, tissue, stool, and lifestyle markers that help predict outcomes.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11210537 on NIH RePORTER

What this research studies

If I join ColoCare, I would be enrolled soon after my colorectal cancer diagnosis and asked to share my medical records, lifestyle information, and symptoms. The team collects biospecimens from me over time, such as blood, stool, urine, and tumor tissue, and follows my health for years to track recurrence, side effects, and survival. Researchers combine those samples with clinical data and questionnaire information to look for biological and behavioral signs linked to better or worse outcomes. The study includes many centers and already has thousands of participants, so it aims to represent people from different places and backgrounds.

Who could benefit from this research

Good fit: Ideal candidates are people newly diagnosed with colorectal cancer who can provide medical records and periodic biospecimens and complete follow-up visits or surveys.

Not a fit: People without colorectal cancer, those unable or unwilling to give specimens or participate in follow-up, or those seeking immediate therapeutic benefit are unlikely to benefit directly from participation.

Why it matters

Potential benefit: If successful, this work could lead to tests and approaches that better predict recurrence and guide personalized follow-up or treatment for colorectal cancer survivors.

How similar studies have performed: Other prospective cancer survivorship cohorts have identified useful risk factors and some biomarkers, but combining serial molecular, microbiome, and lifestyle data across many centers is a relatively advanced and evolving approach.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer PrognosisCancer SurvivorshipCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.